CELU Latest Press Releases

-- October 29, 2026 --

Celularity and Vesalius Longevity Labs Sign Exclusive Collaboration for Peptual Peptide APIs Manufactured in the United States Business Wire 9:00 AM

-- October 22, 2026 --

Celularity Regains Compliance with Nasdaq Periodic Reporting Requirement Globe Newswire 8:00 AM

-- September 30, 2026 --

Celularity Highlights Anticipated Quarter One 2027 Opening of Fontaine Vitale as Strategic Partner Globe Newswire 11:57 AM

-- September 29, 2026 --

Celularity Announces Naveen Jain to Join Board of Directors Globe Newswire 8:30 AM

-- September 24, 2026 --

Celularity Announces Over $10 Million Initial Financing Closing as Part of Up to $28 Million Recapitalization to Accelerate Growth Following Significant Operating Improvements Globe Newswire 9:15 AM

-- August 27, 2026 --

Celularity and MuseCell Innovations Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell Platform Business Wire 9:00 AM

-- August 25, 2026 --

Celularity Provides Update Regarding Nasdaq Listing Compliance Globe Newswire 7:59 PM

-- June 4, 2026 --

Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies Globe Newswire 8:00 AM

-- June 3, 2026 --

Celularity Releases CEO Letter to Shareholders Globe Newswire 4:15 PM

Celularity Appoints Rick Gonzalez as Chief Commercial Officer Globe Newswire 8:00 AM

-- May 29, 2026 --

Celularity Receives Nasdaq Notice Regarding Form 10-Q Globe Newswire 5:15 PM

Market Data Delayed 15 Minutes